1.54
-0.1(-6.10%)
Currency In USD
| Previous Close | 1.64 |
| Open | 1.63 |
| Day High | 1.66 |
| Day Low | 1.53 |
| 52-Week High | 6.69 |
| 52-Week Low | 0.91 |
| Volume | 740,850 |
| Average Volume | 3.75M |
| Market Cap | 128.91M |
| PE | -0.53 |
| EPS | -2.88 |
| Moving Average 50 Days | 1.46 |
| Moving Average 200 Days | 2.5 |
| Change | -0.1 |
If you invested $1000 in Editas Medicine, Inc. (EDIT) since IPO date, it would be worth $84.62 as of May 06, 2025 at a share price of $1.54. Whereas If you bought $1000 worth of Editas Medicine, Inc. (EDIT) shares 5 years ago, it would be worth $61.58 as of May 06, 2025 at a share price of $1.54.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Editas Medicine to Announce First Quarter 2025 Financial Results and to Participate in Investor Conference in May
GlobeNewswire Inc.
12 hours ago
CAMBRIDGE, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced that it plans to announce Q1 2025 financ
Editas Medicine to Present Preclinical Data Demonstrating Progress in the Development of an in vivo Gene Editing Pipeline at the American Society of Gene and Cell Therapy Annual Meeting
GlobeNewswire Inc.
Apr 28, 2025 8:31 PM GMT
CAMBRIDGE, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company, today announced that five abstracts have been accepted for presentation, including one oral presentation, at the 28th Annu
Editas Medicine Announces Chief Financial Officer Transition
GlobeNewswire Inc.
Mar 20, 2025 8:01 PM GMT
Amy Parsion Senior Vice President of Finance Amy Parison Appointed CFO Erick J. Lucera to Step Down as CFO to pursue another opportunity Senior Vice President of Finance Amy Parison Appointed CFO CAMBRIDGE, Mass., March 20, 2025 (GLOBE NEWSWIRE